Literature DB >> 9990297

Uptake and intracellular fate of phage display vectors in mammalian cells.

V Ivanenkov1, F Felici, A G Menon.   

Abstract

Receptor-mediated endocytosis is exploited in experimental systems for selective delivery of genes and drugs into specific cells. To improve targeting efficiency of delivery vectors, we have used phage display technology to isolate novel ligands for endocytosed receptors. We show here that phage vectors internalized by mammalian cells via integrin-mediated endocytosis can be rescued by cell lysis and quantitated by infection of bacteria. Immediately following uptake, phage enter an intracellular compartment where they remain intact, with phage titer unaffected by the addition of chloroquine. Phage are then translocated to a second intracellular compartment in which they are inactivated and their titer affected by chloroquine. Immunofluorescence microscopy showed an association of the second compartment with supranuclear organelles. The ability to recover internalized phage in an infectious form from two distinctive intracellular compartments provides a means to select novel ligands from phage libraries for targeted delivery of macromolecules into mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9990297     DOI: 10.1016/s0167-4889(98)00162-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

Review 1.  Phage Therapy in the Era of Synthetic Biology.

Authors:  E Magda Barbu; Kyle C Cady; Bolyn Hubby
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

2.  Landscape phages and their fusion proteins targeted to breast cancer cells.

Authors:  Olusegun A Fagbohun; Deepa Bedi; Natalia I Grabchenko; Patricia A Deinnocentes; Richard C Bird; Valery A Petrenko
Journal:  Protein Eng Des Sel       Date:  2012-04-06       Impact factor: 1.650

3.  Bacteriophage bionanowire as a carrier for both cancer-targeting peptides and photosensitizers and its use in selective cancer cell killing by photodynamic therapy.

Authors:  Naveen Gandra; Gopal Abbineni; Xuewei Qu; Yanyan Huai; Li Wang; Chuanbin Mao
Journal:  Small       Date:  2012-10-09       Impact factor: 13.281

4.  Selection of Lung Cancer-Specific Landscape Phage for Targeted Drug Delivery.

Authors:  James W Gillespie; Lixia Wei; Valery A Petrenko
Journal:  Comb Chem High Throughput Screen       Date:  2016       Impact factor: 1.339

5.  Clathrin-mediated endocytosis and subsequent endo-lysosomal trafficking of adeno-associated virus/phage.

Authors:  Charlotte A Stoneham; Michael Hollinshead; Amin Hajitou
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

Review 6.  Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Authors:  Mahdi Karimi; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Sajad Bahrami; Mohsen Moghoofei; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2016-03-17       Impact factor: 15.470

7.  Liposomes targeted by fusion phage proteins.

Authors:  Prashanth K Jayanna; Vladimir P Torchilin; Valery A Petrenko
Journal:  Nanomedicine       Date:  2008-10-01       Impact factor: 5.307

8.  Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells.

Authors:  Ramil Sapinoro; Ketna Volcy; W W Shanaka I Rodrigo; Jacob J Schlesinger; Stephen Dewhurst
Journal:  Virology       Date:  2008-01-14       Impact factor: 3.616

9.  Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide.

Authors:  Aeyung Kim; Tae-Hwan Shin; Seung-Min Shin; Chuong D Pham; Dong-Ki Choi; Myung-Hee Kwon; Yong-Sung Kim
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity.

Authors:  Z Yuan; G Syrkin; A Adem; R Geha; J Pastoriza; C Vrikshajanani; T Smith; T J Quinn; G Alemu; H Cho; C J Barrett; W Arap; R Pasqualini; S K Libutti
Journal:  Cancer Gene Ther       Date:  2012-11-16       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.